Revised WHO good practices for pharmaceutical quality control laboratories
The WHO Prequalification of Medicines Programme has posted on its website revised WHO Good Practices for Pharmaceutical Quality Control Laboratories, Annex 1 (WHO T
The WHO Prequalification of Medicines Programme has posted on its website revised WHO Good Practices for Pharmaceutical Quality Control Laboratories, Annex 1 (WHO T
Following re-inspection of Sandoz SA (pty) Ltd, Kempton Park site in South Africa, the WHO Prequalification of Medicines Programme has
In accordance with the provisions set out in sec
Following corrective actions taken by Matrix Laboratories Ltd and the clarifications provided being
WHO is aware of the recent actions taken by the USA Food and Drug Administration (FDA) against the Ranbaxy, Paonta Sahib, India manufacturing site.
As changes in manufacturing sites and activities on sites may change, it is suggested that all users of the list of prequalified products and WHOPIRs verify with the manufacturers
see also: WHO Media Centre: http://www.who.int/entity/mediacentre/news/notes/2005/n
WHO News Release WHO/87, WHO Geneva.
WHO, Geneva.
WHO Geneva.
WHO Geneva. Department of Essential Drugs and Medicines Policy; Department of HIV/AIDS
New edition of WHO prequalification list to include four new anti-AIDS medicines; assessment reports to be made public in coming days
From The New York Times, 16 June 2004
By Lawrence K. Alyman & Donald G. McNeil Jr.
From The New York Times, Thursday, March 21, 2002
Inclusion of products is setback for pharmaceutical giants.
From The New York Times Thursday, March 20, 2002
By Donald G. McNeil Jr.
From The Wall Street Journal, 20 March 2002
By Rachel Zimmerman